1. Home
  2. HSAI vs VERA Comparison

HSAI vs VERA Comparison

Compare HSAI & VERA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

HSAI

Hesai Group each ADS represents one Class B ordinary share

HOLD

Current Price

$26.00

Market Cap

3.7B

Sector

N/A

ML Signal

HOLD

Logo Vera Therapeutics Inc.

VERA

Vera Therapeutics Inc.

HOLD

Current Price

$42.96

Market Cap

3.4B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
HSAI
VERA
Founded
2014
2016
Country
China
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
3.7B
3.4B
IPO Year
2023
2021

Fundamental Metrics

Financial Performance
Metric
HSAI
VERA
Price
$26.00
$42.96
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
4
11
Target Price
$31.58
$76.60
AVG Volume (30 Days)
2.2M
1.0M
Earning Date
03-09-2026
02-25-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
0.44
N/A
Revenue
$385,835,909.00
N/A
Revenue This Year
$56.03
N/A
Revenue Next Year
$39.83
N/A
P/E Ratio
$63.13
N/A
Revenue Growth
43.17
N/A
52 Week Low
$10.41
$18.53
52 Week High
$30.85
$56.05

Technical Indicators

Market Signals
Indicator
HSAI
VERA
Relative Strength Index (RSI) 52.62 43.82
Support Level $23.38 $40.87
Resistance Level $28.38 $44.96
Average True Range (ATR) 1.57 2.18
MACD -0.04 -0.33
Stochastic Oscillator 54.90 27.61

Price Performance

Historical Comparison
HSAI
VERA

About HSAI Hesai Group each ADS represents one Class B ordinary share

Hesai Group is engaged in the development, manufacture, and sales of three-dimensional light detection and ranging solutions, or LiDAR. Its LiDAR products enable a broad spectrum of applications across passenger or commercial vehicles with enhanced advanced driver assistance systems, or ADAS, autonomous vehicle fleets providing passenger and freight mobility services, or Autonomous Mobility, and other applications such as last-mile delivery robots, street sweeping robots, and logistics robots in restricted areas, or Robotics. Geographically, the company operates in North America, Mainland China, Europe, and Other regions.

About VERA Vera Therapeutics Inc.

Vera Therapeutics Inc is a clinical stage biotechnology company. It is focused on developing and commercializing transformative treatments for patients with serious immunological diseases. The company's product candidate is atacicept, a fusion protein self-administered as a subcutaneous injection once weekly that blocks both B lymphocyte stimulator and a proliferation-inducing ligand, which stimulate B cells and plasma cells to produce autoantibodies contributing to certain autoimmune diseases.

Share on Social Networks: